BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Georgiev T, Angelov AK. Complexities of diagnosis and management of COVID-19 in autoimmune diseases: Potential benefits and detriments of immunosuppression. World J Clin Cases 2020; 8(17): 3669-3678 [PMID: 32953843 DOI: 10.12998/wjcc.v8.i17.3669]
URL: https://www.wjgnet.com/1007-9327/full/v8/i17/3669.htm
Number Citing Articles
1
Snejina Vassileva, Valeria Mateeva, Kossara Drenovska. Drug repurposing of dermatologic medications to treat coronavirus disease 2019: Science or fiction?Clinics in Dermatology 2021; 39(3): 430 doi: 10.1016/j.clindermatol.2021.01.020
2
Simona Bogdanova. Musculoskeletal pain in patients with COVID-19Rheumatology (Bulgaria) 2022; : 3 doi: 10.35465/30.2.2022.pp3-17
3
Giulia Costanzo, William Cordeddu, Luchino Chessa, Stefano Del Giacco, Davide Firinu. COVID-19: Considerations about immune suppression and biologicals at the time of SARS-CoV-2 pandemicWorld Journal of Clinical Cases 2021; 9(20): 5352-5357 doi: 10.12998/wjcc.v9.i20.5352
4
Proceedings of the International Conference on Sustainable Innovation on Humanities, Education, and Social Sciences (ICOSI-HESS 2022)2022; : 309 doi: 10.2991/978-2-494069-65-7_27
5
Tsvetelina Velikova, Tsvetoslav Georgiev. SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisisRheumatology International 2021; 41(3): 509 doi: 10.1007/s00296-021-04792-9
6
Georgi Vasilev, Plamena Kabakchieva, Dimitrina Miteva, Hristiana Batselova, Tsvetelina Velikova. Effectiveness and safety of COVID-19 vaccines in patients with diabetes as a factor for vaccine hesitancyWorld Journal of Diabetes 2022; 13(9): 738-751 doi: 10.4239/wjd.v13.i9.738
7
Metodija Sekulovski, Simona Bogdanova-Petrova, Monika Peshevska-Sekulovska, Tsvetelina Velikova, Tsvetoslav Georgiev. COVID-19 related liver injuries in pregnancyWorld Journal of Clinical Cases 2023; 11(9): 1918-1929 doi: 10.12998/wjcc.v11.i9.1918
8
Alexia Plocque, Christie Mitri, Charlène Lefèvre, Olivier Tabary, Lhousseine Touqui, Francois Philippart. Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far?Drugs 2023; 83(1): 1 doi: 10.1007/s40265-022-01803-2
9
Sehnaz Olgun Yıldızeli, Duygu Vezir, Canan Cimsit, Derya Kocakaya, Zeynep Mercanci, Baran Balcan, Onur Ermerak, Can Ilgin, Emel Eryuksel, Sait Karakurt. Pre-existing Immunocompromised Status as a Preventer of Mortality in COVID-19 Patients: Friend or Foe?Cureus 2023;  doi: 10.7759/cureus.37633